PubRank

David J Goldberg

Author PubWeight™ 94.17‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Hepatitis C virus treatment for prevention among people who inject drugs: Modeling treatment scale-up in the age of direct-acting antivirals. Hepatology 2013 2.76
2 18 years of the Fontan operation at a single institution: results from 771 consecutive patients. J Am Coll Cardiol 2012 2.24
3 Modeling the current and future disease burden of hepatitis C among injection drug users in Scotland. Hepatology 2005 1.91
4 Excess liver-related morbidity of chronic hepatitis C patients, who achieve a sustained viral response, and are discharged from care. Hepatology 2011 1.68
5 Cost-effectiveness of hepatitis C virus antiviral treatment for injection drug user populations. Hepatology 2011 1.67
6 The precarious state of the liver after a Fontan operation: summary of a multidisciplinary symposium. Pediatr Cardiol 2012 1.62
7 Treatment of hepatitis C virus infection among people who are actively injecting drugs: a systematic review and meta-analysis. Clin Infect Dis 2013 1.61
8 High-fluence and high-density treatment of perioral rhytides using a new, fractionated 2,790-nm ablative erbium-doped Yttrium Scandium Gallium Garnet Laser. Dermatol Surg 2011 1.60
9 Influence of alcohol on the progression of hepatitis C virus infection: a meta-analysis. Clin Gastroenterol Hepatol 2005 1.53
10 Can antiviral therapy for hepatitis C reduce the prevalence of HCV among injecting drug user populations? A modeling analysis of its prevention utility. J Hepatol 2011 1.50
11 Outcomes of Single-Ventricle Patients Supported With Extracorporeal Membrane Oxygenation. Pediatr Crit Care Med 2016 1.42
12 Combination interventions to prevent HCV transmission among people who inject drugs: modeling the impact of antiviral treatment, needle and syringe programs, and opiate substitution therapy. Clin Infect Dis 2013 1.38
13 A multistep approach to improving biopsy site identification in dermatology: physician, staff, and patient roles based on a Delphi consensus. JAMA Dermatol 2014 1.37
14 Are needle and syringe programmes associated with a reduction in HIV transmission among people who inject drugs: a systematic review and meta-analysis. Int J Epidemiol 2013 1.23
15 Portal and sinusoidal fibrosis are common on liver biopsy after Fontan surgery. Pediatr Cardiol 2012 1.18
16 Association of self-reported alcohol use and hospitalization for an alcohol-related cause in Scotland: a record-linkage study of 23,183 individuals. Addiction 2009 1.18
17 Nd:YAG laser (1064 nm) irradiation for lower extremity telangiectases and small reticular veins: efficacy as measured by vessel color and size. Dermatol Surg 2002 1.17
18 A review of laser and photodynamic therapy for the treatment of nonmelanoma skin cancer. Dermatol Surg 2004 1.07
19 A population-based record linkage study of mortality in hepatitis C-diagnosed persons with or without HIV coinfection in Scotland. Stat Methods Med Res 2008 1.03
20 The use of photodynamic therapy in dermatology: results of a consensus conference. J Drugs Dermatol 2006 1.03
21 Radiofrequency in cosmetic dermatology: a review. Dermatol Surg 2012 1.00
22 Dermal fillers: complications and informed consent. J Cosmet Laser Ther 2005 1.00
23 Topical anesthetics for cosmetic and laser dermatology. J Drugs Dermatol 2005 0.99
24 Failure of the fontan circulation. Heart Fail Clin 2014 0.99
25 Mesotherapy for facial skin rejuvenation: a clinical, histologic, and electron microscopic evaluation. Dermatol Surg 2006 0.98
26 Clinical, histologic and electron microscopic findings after injection of a calcium hydroxylapatite filler. J Cosmet Laser Ther 2004 0.98
27 Extraocular sebaceous carcinoma treated with Mohs micrographic surgery: report of a case and review of literature. Dermatol Surg 2007 0.97
28 Association between harm reduction intervention uptake and recent hepatitis C infection among people who inject drugs attending sites that provide sterile injecting equipment in Scotland. Int J Drug Policy 2012 0.95
29 Calcium hydroxylapatite filler for facial rejuvenation: a histologic and immunohistochemical analysis. Dermatol Surg 2008 0.95
30 Detection of hepatitis C virus RNA in dried blood spots. J Clin Virol 2012 0.94
31 Decrease in health-related quality of life associated with awareness of hepatitis C virus infection among people who inject drugs in Scotland. J Hepatol 2012 0.94
32 Anthrax infection among heroin users in Scotland during 2009-2010: a case-control study by linkage to a national drug treatment database. Clin Infect Dis 2012 0.93
33 Infections with spore-forming bacteria in persons who inject drugs, 2000-2009. Emerg Infect Dis 2013 0.93
34 Atrophic and a mixed pattern of acne scars improved with a 1320-nm Nd:YAG laser. Dermatol Surg 2003 0.93
35 Laser lipolysis of the arm, with and without suction aspiration: clinical and histologic changes. J Cosmet Laser Ther 2009 0.93
36 Drug-related deaths by region, sex, and age group per 100 injecting drug users in Scotland, 2000-01. Lancet 2003 0.93
37 Ultrastructural changes seen after ALA-IPL photorejuvenation: a pilot study. J Cosmet Laser Ther 2005 0.92
38 How do centres begin the process to prevent contrast-induced acute kidney injury: a report from a new regional collaborative. BMJ Qual Saf 2011 0.91
39 A prospective study of fractional scanned nonsequential carbon dioxide laser resurfacing: a clinical and histopathologic evaluation. Dermatol Surg 2009 0.90
40 Clinical, histologic, and ultrastructural changes after use of human growth factor and cytokine skin cream for the treatment of skin rejuvenation. J Cosmet Laser Ther 2008 0.90
41 Prevalence and determinants of hepatitis C virus infection among female drug injecting sex workers in Glasgow. Harm Reduct J 2008 0.90
42 Complications from injectable polyacrylamide gel, a new nonbiodegradable soft tissue filler. Dermatol Surg 2004 0.90
43 Ablative skin resurfacing. Curr Probl Dermatol 2011 0.90
44 Clinical comparison of four hair removal lasers and light sources. J Cosmet Laser Ther 2006 0.90
45 Safety and efficacy of intradermal injection of botulinum toxin for the treatment of oily skin. Dermatol Surg 2013 0.89
46 Use of phosphatidylcholine for the correction of lower lid bulging due to prominent fat pads. J Cosmet Laser Ther 2006 0.89
47 Vascular-specific laser wavelength for the treatment of facial telangiectasias. J Drugs Dermatol 2009 0.89
48 Calcium hydroxylapatite for facial rejuvenation. Semin Cutan Med Surg 2006 0.87
49 Radiofrequency in Cosmetic Dermatology: An Update. J Drugs Dermatol 2015 0.87
50 The efficacy and safety of a new U.S. Botulinum toxin type A in the retreatment of glabellar lines following open-label treatment. J Drugs Dermatol 2009 0.86
51 Recent advances in laser dermatology. J Cosmet Laser Ther 2009 0.86
52 Supplemental tube feeding does not mitigate weight loss in infants with shunt-dependent single-ventricle physiology. Pediatr Cardiol 2013 0.86
53 Nonablative facial remodeling: erythema reduction and histologic evidence of new collagen formation using a 300-microsecond 1064-nm Nd:YAG laser. Arch Dermatol 2004 0.85
54 308-nm Excimer laser treatment of mature hypopigmented striae. Dermatol Surg 2003 0.85
55 Prevalence of deficient retro-aortic rim and its effects on outcomes in device closure of atrial septal defects. Pediatr Cardiol 2014 0.85
56 A review of sutures and other skin closure materials. J Cosmet Laser Ther 2010 0.84
57 Ranking predictors of a sustained viral response for patients with chronic hepatitis C treated with pegylated interferon and ribavirin in Scotland. Eur J Gastroenterol Hepatol 2012 0.84
58 Assessment of safety and efficacy of a bipolar fractionated radiofrequency device in the treatment of photodamaged skin. J Cosmet Laser Ther 2012 0.83
59 Treatment of melasma with low fluence, large spot size, 1064-nm Q-switched neodymium-doped yttrium aluminum garnet (Nd:YAG) laser for the treatment of melasma in Fitzpatrick skin types II-IV. J Cosmet Laser Ther 2011 0.83
60 Controlled volumetric heating of subcutaneous adipose tissue using a novel radiofrequency technology. Lasers Surg Med 2009 0.83
61 Trends in the incidence of HIV in Scotland, 1988-2009. Sex Transm Infect 2011 0.83
62 Sudden rise in uptake of hepatitis B vaccination among injecting drug users associated with a universal vaccine programme in prisons. Vaccine 2004 0.82
63 Evaluation of a new super-long-pulsed 810 nm diode laser for the removal of unwanted hair: the concept of thermal damage time. Dermatol Surg 2002 0.82
64 Electrosurgical resurfacing: a clinical, histologic, and electron microscopic evaluation. Lasers Surg Med 2003 0.82
65 Millisecond 1064-nm neodymium:YAG laser treatment of facial telangiectases. Dermatol Surg 2003 0.82
66 Laser hair removal pearls. J Cosmet Laser Ther 2008 0.81
67 Suture material in cosmetic cutaneous surgery. J Cosmet Laser Ther 2007 0.81
68 Digital photography, confidentiality, and teledermatology. Arch Dermatol 2004 0.81
69 Safety and efficacy of fractional bipolar radiofrequency treatment in Fitzpatrick skin types V-VI. J Cosmet Laser Ther 2012 0.80
70 Novel hyaluronic acid dermal filler: dermal gel extra physical properties and clinical outcomes. Dermatol Surg 2010 0.80
71 Use of oral budesonide in the management of protein-losing enteropathy after the Fontan operation. Ann Thorac Surg 2010 0.80
72 Multicenter study comparing shunt type in the norwood procedure for single-ventricle lesions: three-dimensional echocardiographic analysis. Circ Cardiovasc Imaging 2013 0.80
73 Quantifying the fraction of cirrhosis attributable to alcohol among chronic hepatitis C virus patients: implications for treatment cost-effectiveness. Hepatology 2013 0.79
74 A hepatitis C avidity test for determining recent and past infections in both plasma and dried blood spots. J Clin Virol 2013 0.79
75 Hospitalisation for an alcohol-related cause among injecting drug users in Scotland: increased risk following diagnosis with hepatitis C infection. Int J Drug Policy 2010 0.79
76 Nonablative dermal remodeling: does it really work? Arch Dermatol 2002 0.79
77 Benign pigmented lesions. Curr Probl Dermatol 2011 0.79
78 Energy-Based Devices in Treatment of Acne Vulgaris. Dermatol Surg 2016 0.79
79 Intense pulsed light: what works, what's new, what's next. Facial Plast Surg 2009 0.78
80 Evaluation of histologic and electron microscopic changes after novel treatment using combined microdermabrasion and ultrasound-induced phonophoresis of human skin. J Cosmet Laser Ther 2008 0.78
81 Hospitalization of hepatitis C-diagnosed individuals in Scotland for decompensated cirrhosis: a population-based record-linkage study. Eur J Gastroenterol Hepatol 2010 0.78
82 The prevalence of hepatitis C virus among people of South Asian origin in Glasgow - results from a community based survey and laboratory surveillance. Travel Med Infect Dis 2013 0.78
83 Superficial erbium:YAG laser resurfacing of photodamaged skin. J Cosmet Laser Ther 2006 0.78
84 Non-ablative lasers. Curr Probl Dermatol 2011 0.78
85 The association between alcohol use and hepatitis C status among injecting drug users in Glasgow. Drug Alcohol Depend 2011 0.78
86 Review and meta-analysis of the association between self-reported sharing of needles/syringes and hepatitis C virus prevalence and incidence among people who inject drugs in Europe. Int J Drug Policy 2012 0.78
87 Examination of the risk of reinfection with hepatitis C among injecting drug users who have been tested in Glasgow. Int J Drug Policy 2012 0.78
88 Botulinum B treatment of the glabellar and frontalis regions: a dose response analysis. J Cosmet Laser Ther 2002 0.77
89 Brain-type natriuretic peptide correlates with right heart pressures in a cross section of pediatric heart transplant patients. Pediatr Transplant 2010 0.77
90 Patient compliance as a major determinant of laser tattoo removal success rates: a 10-year retrospective study. J Cosmet Laser Ther 2010 0.77
91 A split-face comparison of two ablative fractional carbon dioxide lasers for the treatment of photodamaged facial skin. Dermatol Surg 2011 0.77
92 Cutaneous photoaging treated with a combined 595/1064 nm laser. J Cosmet Laser Ther 2007 0.77
93 Fractional ablative laser skin resurfacing: a review. J Cosmet Laser Ther 2011 0.77
94 Impact of intradermal abobotulinumtoxinA on facial erythema of rosacea. Dermatol Surg 2015 0.76
95 Laser-assisted hair removal in Asian skin: efficacy, complications, and the effect of single versus multiple treatments. Dermatol Surg 2003 0.76
96 Review of models used to predict the future numbers of individuals with severe hepatitis C disease: therapeutic and cost implications. Expert Rev Pharmacoecon Outcomes Res 2006 0.76
97 Evaluation of clinical, microscopic, and ultrastructural changes after treatment with a novel Q-switched Nd:YAG laser. J Cosmet Laser Ther 2008 0.76
98 Laser treatment of facial telangiectases: an update. Dermatol Surg 2010 0.75
99 Evaluation of a long-pulsed Nd:YAG laser at different parameters: an analysis of both fluence and pulse duration. Dermatol Surg 2002 0.75
100 The prevalence and impact of thrombocytopenia, anaemia and leucopenia on sustained virological response in patients receiving hepatitis C therapy: evidence from a large 'real world' cohort. Eur J Gastroenterol Hepatol 2016 0.75
101 The value of genitourinary medicine clinics in the recognition and diagnosis of new cases of hepatitis C in the United Kingdom. Int J STD AIDS 2002 0.75
102 HPV vaccine: positive insights from universal adolescent HepB vaccination. J Epidemiol Community Health 2007 0.75
103 Reply: To PMID 22818071. J Am Coll Cardiol 2013 0.75
104 Journal of Cosmetic and Laser Therapy. Editorial. J Cosmet Laser Ther 2010 0.75
105 Journal of Cosmetic and Laser Therapy. Editorial. J Cosmet Laser Ther 2010 0.75
106 Laser therapy and treatment. Editorial. J Cosmet Laser Ther 2010 0.75
107 Treatment of port wine stains. J Cosmet Laser Ther 2010 0.75
108 Journal of Cosmetic and Laser Therapy. Editorial. J Cosmet Laser Ther 2012 0.75
109 ASDS Cosmetic Dermatologic Surgery Fellowship Milestones. Dermatol Surg 2016 0.75
110 Expert Consensus on Cosmetic Outcomes After Treatment of Actinic Keratosis. J Drugs Dermatol 2017 0.75
111 Fractional laser resurfacing. J Cosmet Laser Ther 2011 0.75
112 Photodamage therapy using an electro-optic Q-switched Nd:YAG laser. Lasers Surg Med 2010 0.75
113 Mixture of available cosmetic treatments and novel new concepts. J Cosmet Laser Ther 2009 0.75
114 Journal of Cosmetic and Laser Therapy. Editorial. J Cosmet Laser Ther 2010 0.75
115 Laser safety. Curr Probl Dermatol 2011 0.75
116 Human immunodeficiency virus acquired heterosexually abroad: expert panel assessment of the "indigenous/nonindigenous to the United kingdom status" of cases. J Travel Med 2005 0.75
117 Editorial: this issue of the journal. J Cosmet Laser Ther 2013 0.75
118 Laser treatments and the use of fillers. Editorial. J Cosmet Laser Ther 2008 0.75
119 Expert Consensus on Absorbable Advanced Suspension Technology for Facial Tissue Repositioning and Volume Enhancement. J Drugs Dermatol 2017 0.75
120 A diverse array of cosmetic topics. J Cosmet Laser Ther 2006 0.75
121 Use of multispectral digital skin lesion analysis for evaluation of nevi in children. J Drugs Dermatol 2014 0.75
122 Use of a biopolymer polyalkylimide filler for facial lipodystrophy in HIV-positive patients undergoing treatment with antiretroviral drugs. Dermatol Surg 2006 0.75
123 Perioral rejuvenation. Aesthet Surg J 2003 0.75
124 Clinical Evaluation of Hair Removal Using an 810 nm Diode Laser With a Novel Scanning Device. J Drugs Dermatol 2016 0.75
125 Longer wavelength vascular lasers may now give patients a choice beyond surgery. J Cosmet Laser Ther 2009 0.75
126 Successful treatment of facial telangiectasias using a micropulse 1,064-nm neodymium-doped yttrium aluminum garnet laser. Dermatol Surg 2013 0.75
127 Energy-based technologies. J Cosmet Laser Ther 2013 0.75
128 Nonablative laser technology Radiofrequency. Aesthet Surg J 2009 0.75
129 Glucose control in acute myocardial infarction: a pilot randomized study controlled by continuous glucose monitoring system comparing the use of insulin glargine with standard of care. Diabetes Technol Ther 2011 0.75
130 Editorial. J Cosmet Laser Ther 2009 0.75
131 Botulinum toxin injections have become a main-stay in the treatment of aging skin. J Cosmet Laser Ther 2008 0.75
132 Small-Particle Hyaluronic Acid Gel Treatment of Photoaged Hands. Dermatol Surg 2017 0.75
133 Assessment of safety and efficacy of a bipolar fractionated radiofrequency device in the treatment of periorbital rhytides. J Cosmet Laser Ther 2014 0.75
134 LASERS and the LAW: what the dermatologist needs to know. Semin Cutan Med Surg 2013 0.75
135 Clinical and Histologic Evaluation of Ingenol Mebutate 0.015% Gel for the Cosmetic Improvement of Photoaged Skin. Dermatol Surg 2017 0.75
136 Cardiovascular perforation during placement of an Avalon Elite® Bicaval dual lumen ECMO cannula in a newborn. J Card Surg 2014 0.75
137 Treatment of photoaging with a very superficial Er:YAG laser in combination with a broadband light source. J Drugs Dermatol 2007 0.75
138 Open-label evaluation of the skin-brightening efficacy of a skin-brightening system using decapeptide-12. J Cosmet Laser Ther 2012 0.75
139 Editorial. J Cosmet Laser Ther 2007 0.75
140 Nonablative laser resurfacing: state of the art 2002. Aesthet Surg J 2002 0.75
141 With this filler/volumizing agent now becoming available, the interest in non-surgical facial sculpturing will continue to expand. J Cosmet Laser Ther 2008 0.75
142 Assessment of the safety and efficacy of a bipolar multi-frequency radiofrequency device in the treatment of skin laxity. J Cosmet Laser Ther 2013 0.75
143 Topical manganese peptide in the treatment of photodamaged skin. J Cosmet Laser Ther 2007 0.75